Comparative Pharmacology
Head-to-head clinical analysis: AMMONUL versus GLYCEROL PHENYLBUTYRATE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AMMONUL versus GLYCEROL PHENYLBUTYRATE.
AMMONUL vs GLYCEROL PHENYLBUTYRATE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Ammonul (sodium phenylacetate and sodium benzoate) provides an alternative pathway for nitrogen excretion. Phenylacetate conjugates with glutamine to form phenylacetylglutamine, which is excreted by the kidneys. Benzoate conjugates with glycine to form hippurate, which is also excreted renally. This reduces ammonia levels in patients with urea cycle disorders.
Glycerol phenylbutyrate is a prodrug that is metabolized to phenylacetate, which conjugates with glutamine to form phenylacetylglutamine. This compound is excreted by the kidneys, providing an alternative pathway for waste nitrogen excretion in patients with urea cycle disorders.
For acute hyperammonemia: 2.5 g/m² IV over 90 minutes, followed by continuous IV infusion at 2.5 g/m² over 24 hours. For maintenance: 2.5 g/m² IV or oral every 6 hours.
450-600 mg/m2/day orally in three divided doses, rounded to the nearest 100 mg; maximum 20 g/day.
None Documented
None Documented
Clinical Note
moderateGlycerol phenylbutyrate + Fesoterodine
"The serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Glycerol phenylbutyrate."
Clinical Note
moderateGlycerol phenylbutyrate + Atorvastatin
"The risk or severity of adverse effects can be increased when Glycerol phenylbutyrate is combined with Atorvastatin."
Clinical Note
moderatePrednisolone + Glycerol phenylbutyrate
"The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Prednisolone."
Clinical Note
moderatePhenylacetate: 0.5-1 hour; phenylacetylglutamine: 1-2 hours. Clinical context: rapid clearance; requires continuous IV infusion for sustained effect.
0.8–1 hours (glycerol phenylbutyrate); 1.2–1.5 hours (phenylacetate); clinical context: short half-life requires thrice-daily dosing
Renal: >80% (primarily as phenylacetylglutamine). Biliary/fecal: <5%.
Renal: >90% as phenylbutyrate metabolites (mainly phenylacetylglutamine) within 24 hours; fecal: <1%
Category C
Category C
Ammonia Detoxicant
Ammonia Detoxicant
Dexamethasone + Glycerol phenylbutyrate
"The therapeutic efficacy of Glycerol phenylbutyrate can be decreased when used in combination with Dexamethasone."